AstraZeneca said it would invest $630 million into Korea’s biotech and healthcare sector over the next five years.
Leif Johansson, chairman of the British-Swedish drugmaker, announced the plan at the Korea-Sweden Business Summit, attended by President Moon Jae-in, Swedish King Carl XVI Gustaf, and Swedish Prime Minister Stefan Löfven in Stockholm on Friday, local time. The business summit was held as part of President Moon’s state visit.
{iframe}http://www.koreabiomed.com/news/articleView.html?idxno=5932{/iframe}